These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8130858)

  • 21. Clinical pharmacokinetics of antimicrobial drugs in cystic fibrosis.
    Touw DJ
    Pharm World Sci; 1998 Aug; 20(4):149-60. PubMed ID: 9762727
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetic properties of bromide in dogs after the intravenous and oral administration of single doses.
    Trepanier LA; Babish JG
    Res Vet Sci; 1995 May; 58(3):248-51. PubMed ID: 7659850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin sensitivity and metabolic clearance rate of insulin in cystic fibrosis.
    Ahmad T; Nelson R; Taylor R
    Metabolism; 1994 Feb; 43(2):163-7. PubMed ID: 8121296
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of oral and intravenous bromide in normal volunteers.
    Vaiseman N; Koren G; Pencharz P
    J Toxicol Clin Toxicol; 1986; 24(5):403-13. PubMed ID: 3783804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cefepime. Pharmacokinetics and clinical response in patients with cystic fibrosis.
    Arguedas AG; Stutman HR; Zaleska M; Knupp CA; Marks MI; Nussbaum E
    Am J Dis Child; 1992 Jul; 146(7):797-802. PubMed ID: 1496945
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Caloric intake and eating behavior in infants and toddlers with cystic fibrosis.
    Powers SW; Patton SR; Byars KC; Mitchell MJ; Jelalian E; Mulvihill MM; Hovell MF; Stark LJ
    Pediatrics; 2002 May; 109(5):E75-5. PubMed ID: 11986481
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of contraceptive steroids in patients with cystic fibrosis.
    Stead RJ; Grimmer SF; Rogers SM; Back DJ; Orme ML; Hodson ME; Batten JC
    Thorax; 1987 Jan; 42(1):59-64. PubMed ID: 3112991
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of netilmicin in children with and without cystic fibrosis.
    Michalsen H; Bergan T
    Antimicrob Agents Chemother; 1981 Jun; 19(6):1029-31. PubMed ID: 7271272
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased nonrenal clearance and increased diuretic efficiency of furosemide in cystic fibrosis.
    Alván G; Beermann B; Hjelte L; Lind M; Lindholm A; Strandvik B
    Clin Pharmacol Ther; 1988 Oct; 44(4):436-41. PubMed ID: 3168395
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical pharmacokinetics of drugs in obesity. An update.
    Cheymol G
    Clin Pharmacokinet; 1993 Aug; 25(2):103-14. PubMed ID: 8403734
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Theophylline disposition in cystic fibrosis.
    Isles A; Spino M; Tabachnik E; Levison H; Thiessen J; MacLeod S
    Am Rev Respir Dis; 1983 Apr; 127(4):417-21. PubMed ID: 6838048
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bromide kinetics and distribution in the rat. II. Distribution of bromide in the body.
    Pavelka S; Babický A; Vobecký M; Lener J
    Biol Trace Elem Res; 2000 Jul; 76(1):67-74. PubMed ID: 10999431
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Leucine metabolism and body cell mass in cystic fibrosis.
    Shepherd RW; Holt TL; Johnson LP; Quirk P; Thomas BJ
    Nutrition; 1995; 11(2):138-41. PubMed ID: 7647476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Population pharmacokinetics of high dose ibuprofen in cystic fibrosis.
    Arranz I; Martín-Suárez A; Lanao JM; Mora F; Vázquez C; Escribano A; Juste M; Mercader J; Ripoll E
    Arch Dis Child; 2003 Dec; 88(12):1128-30. PubMed ID: 14670788
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The bioavailability and pharmacokinetics of cimetidine and its metabolites in juvenile cystic fibrosis patients: age related differences as compared to adults.
    Ziemniak JA; Assael BM; Padoan R; Schentag JJ
    Eur J Clin Pharmacol; 1984; 26(2):183-9. PubMed ID: 6723756
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors limiting anaerobic performance in adolescent males with cystic fibrosis.
    Boas SR; Joswiak ML; Nixon PA; Fulton JA; Orenstein DM
    Med Sci Sports Exerc; 1996 Mar; 28(3):291-8. PubMed ID: 8776217
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum glutathione reductase and cystic fibrosis.
    Shapiro BL; Smith QT; Warick WJ
    Pediatr Res; 1975 Dec; 9(12):885-8. PubMed ID: 1196705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of azlocillin in children with and without cystic fibrosis treated for infectious diseases.
    Michalsen H; Bergan T
    Methods Find Exp Clin Pharmacol; 1986 Dec; 8(12):727-9. PubMed ID: 3807473
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease.
    Smith WB; Dowell JA; Pratt RD
    Clin Ther; 2007 Jul; 29(7):1368-80. PubMed ID: 17825688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.